Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways

There is increased investigation of the human microbiome as it relates to health and disease. Dysbiosis is implicated in various clinical conditions including inflammatory bowel disease (IBD). Probiotics have b...

Full description

Saved in:
Bibliographic Details
Main Authors: Sonia S. Yoon, Jun Sun
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2011/971938
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850167821778026496
author Sonia S. Yoon
Jun Sun
author_facet Sonia S. Yoon
Jun Sun
author_sort Sonia S. Yoon
collection DOAJ
description There is increased investigation of the human microbiome as it relates to health and disease. Dysbiosis is implicated in various clinical conditions including inflammatory bowel disease (IBD). Probiotics have been explored as a potential treatment for IBD and other diseases. The mechanism of action for probiotics has yet to be fully elucidated. This paper discusses novel mechanisms of action for probiotics involving anti-inflammatory signaling pathways. We highlight recent progress in probiotics and nuclear receptor signaling, such as peroxisome-proliferator-activated receptor gamma (PPARγ) and vitamin D receptor (VDR). We also discuss future areas of investigation.
format Article
id doaj-art-dfab08c6111d4c539107e24d2a25537c
institution OA Journals
issn 1687-6121
1687-630X
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-dfab08c6111d4c539107e24d2a25537c2025-08-20T02:21:07ZengWileyGastroenterology Research and Practice1687-61211687-630X2011-01-01201110.1155/2011/971938971938Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory PathwaysSonia S. Yoon0Jun Sun1Division of Gastroenterology and Hepatology, Department of Medicine, Strong Memorial Hospital, University of Rochester Mediacal Center, University of Rochester, Rochester, NY 14642, USADivision of Gastroenterology and Hepatology, Department of Medicine, Strong Memorial Hospital, University of Rochester Mediacal Center, University of Rochester, Rochester, NY 14642, USAThere is increased investigation of the human microbiome as it relates to health and disease. Dysbiosis is implicated in various clinical conditions including inflammatory bowel disease (IBD). Probiotics have been explored as a potential treatment for IBD and other diseases. The mechanism of action for probiotics has yet to be fully elucidated. This paper discusses novel mechanisms of action for probiotics involving anti-inflammatory signaling pathways. We highlight recent progress in probiotics and nuclear receptor signaling, such as peroxisome-proliferator-activated receptor gamma (PPARγ) and vitamin D receptor (VDR). We also discuss future areas of investigation.http://dx.doi.org/10.1155/2011/971938
spellingShingle Sonia S. Yoon
Jun Sun
Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
Gastroenterology Research and Practice
title Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
title_full Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
title_fullStr Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
title_full_unstemmed Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
title_short Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways
title_sort probiotics nuclear receptor signaling and anti inflammatory pathways
url http://dx.doi.org/10.1155/2011/971938
work_keys_str_mv AT soniasyoon probioticsnuclearreceptorsignalingandantiinflammatorypathways
AT junsun probioticsnuclearreceptorsignalingandantiinflammatorypathways